Piccart MJ - Search Results

1

Resistance to trastuzumab: a necessary evil or a temporary challenge?

Cardoso F, Piccart MJ, Durbecq V, Di Leo A. Cardoso F, et al. Among authors: piccart mj. Clin Breast Cancer. 2002 Oct;3(4):247-57; discussion 258-9. doi: 10.3816/CBC.2002.n.028. Clin Breast Cancer. 2002. PMID: 12425752 Review.

2

Treatment of advanced breast cancer: current status.

Piccart M. Piccart M. Anticancer Drugs. 1996 Aug;7 Suppl 2:5-7. Anticancer Drugs. 1996. PMID: 8862702 Review.

3

Tamoxifen aziridine labeling of the estrogen receptor-potential utility in detecting biologically aggressive breast tumors.

Trivedi S, Piccart M, Muquardt C, Gilot N, Hadiy S, Patel D, Leclercq G. Trivedi S, et al. Breast Cancer Res Treat. 1996;40(3):231-41. doi: 10.1007/BF01806811. Breast Cancer Res Treat. 1996. PMID: 8883965

4

Conclusions: future strategies in the treatment of breast cancer.

Piccart MJ, Hortobagyi GN. Piccart MJ, et al. Semin Oncol. 1997 Feb;24(1 Suppl 3):S34-40. Semin Oncol. 1997. PMID: 9071339 Review.

5

Future perspectives of docetaxel (Taxotere) in front-line therapy.

Piccart MJ, Di Leo A. Piccart MJ, et al. Semin Oncol. 1997 Aug;24(4 Suppl 10):S10-27-S10-33. Semin Oncol. 1997. PMID: 9275004 Review.

6

Breast cancer therapies in development. A review of their pharmacology and clinical potential.

de Valeriola D, Awada A, Roy JA, Di Leo A, Biganzoli L, Piccart M. de Valeriola D, et al. Drugs. 1997 Sep;54(3):385-413. doi: 10.2165/00003495-199754030-00003. Drugs. 1997. PMID: 9279502 Review.

7

Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome.

Lespagnard L, Gancberg D, Rouas G, Leclercq G, de Saint-Aubain Somerhausen N, Di Leo A, Piccart M, Verhest A, Larsimont D. Lespagnard L, et al. Int J Cancer. 1999 Jun 21;84(3):309-14. doi: 10.1002/(sici)1097-0215(19990621)84:3<309::aid-ijc19>3.0.co;2-3. Int J Cancer. 1999. PMID: 10371352

8

Paclitaxel activity, dose, and schedule: data from phase III trials in metastatic breast cancer.

Di Leo A, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Semin Oncol. 1999 Jun;26(3 Suppl 8):27-32. Semin Oncol. 1999. PMID: 10403471 Review.

9

A feasibility study evaluating docetaxel-based sequential and combination regimens in the adjuvant therapy of node-positive breast cancer.

Di Leo A, Crown J, Nogaret JM, Duffy K, Bartholomeus S, Dolci S, Rowan S, O'Higgins N, Paesmans M, Larsimont D, Riva A, Piccart MJ. Di Leo A, et al. Among authors: piccart mj. Ann Oncol. 2000 Feb;11(2):169-75. doi: 10.1023/a:1008345432342. Ann Oncol. 2000. PMID: 10761751 Free article. Clinical Trial.

10

The impact of chemotherapy dose density and dose intensity on breast cancer outcome: what have we learned?

Piccart MJ, Biganzoli L, Di Leo A. Piccart MJ, et al. Eur J Cancer. 2000 Apr;36 Suppl 1:S4-10. doi: 10.1016/s0959-8049(99)00256-7. Eur J Cancer. 2000. PMID: 10785603 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

605 results

Search Page

Filters